Mettler-Toledo International Inc. (NYSE:MTD) Shares Sold by BNP PARIBAS ASSET MANAGEMENT Holding S.A.

BNP PARIBAS ASSET MANAGEMENT Holding S.A. lowered its stake in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 5.8% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 33,468 shares of the medical instruments supplier’s stock after selling 2,043 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A.’s holdings in Mettler-Toledo International were worth $50,192,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in MTD. EverSource Wealth Advisors LLC boosted its position in shares of Mettler-Toledo International by 8.0% during the 1st quarter. EverSource Wealth Advisors LLC now owns 95 shares of the medical instruments supplier’s stock valued at $117,000 after acquiring an additional 7 shares during the last quarter. UMB Bank n.a. grew its stake in shares of Mettler-Toledo International by 6.6% in the 2nd quarter. UMB Bank n.a. now owns 113 shares of the medical instruments supplier’s stock valued at $158,000 after buying an additional 7 shares during the period. Bellevue Group AG grew its stake in shares of Mettler-Toledo International by 32.0% in the 1st quarter. Bellevue Group AG now owns 33 shares of the medical instruments supplier’s stock valued at $44,000 after buying an additional 8 shares during the period. Massmutual Trust Co. FSB ADV increased its holdings in shares of Mettler-Toledo International by 7.2% during the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 119 shares of the medical instruments supplier’s stock worth $166,000 after buying an additional 8 shares during the last quarter. Finally, DT Investment Partners LLC raised its position in shares of Mettler-Toledo International by 13.3% during the 3rd quarter. DT Investment Partners LLC now owns 68 shares of the medical instruments supplier’s stock valued at $102,000 after buying an additional 8 shares during the period. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Mettler-Toledo International Stock Performance

NYSE MTD opened at $1,195.00 on Friday. The firm has a market cap of $25.21 billion, a price-to-earnings ratio of 32.22, a PEG ratio of 3.83 and a beta of 1.16. The firm has a 50 day simple moving average of $1,365.15 and a 200-day simple moving average of $1,398.13. Mettler-Toledo International Inc. has a one year low of $1,059.08 and a one year high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, beating the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. The company had revenue of $954.54 million during the quarter, compared to analysts’ expectations of $941.93 million. Equities analysts predict that Mettler-Toledo International Inc. will post 40.39 EPS for the current fiscal year.

Insider Buying and Selling

In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of the stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the sale, the director now owns 240 shares of the company’s stock, valued at $314,820. This trade represents a 24.05 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.94% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on MTD. Evercore ISI increased their price objective on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 1st. Wells Fargo & Company lowered their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a report on Monday, November 11th. Stifel Nicolaus cut their price objective on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. Robert W. Baird decreased their target price on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a research report on Monday, November 11th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a research report on Monday, August 5th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $1,338.75.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.